KBC Group’s Select Medical SEM Stock Holding History

KBC Group’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56K	Sell	3,393 -2,443	-42%	-$40.3K	﹤0.01%	1673
2026 Q1	$95K	Hold	5,836	–	–	﹤0.01%	1349
2025 Q4	$87K	Hold	5,836	–	–	﹤0.01%	1385
2025 Q3	$75K	Buy	5,836 +2,619	+81%	+$34.9K	﹤0.01%	1450
2025 Q2	$49K	Sell	3,217 -1,895	-37%	-$29.6K	﹤0.01%	1616
2025 Q1	$85K	Sell	5,112 -9,771	-66%	-$180K	﹤0.01%	1576
2024 Q4	$281K	Sell	14,883 -9,338	-39%	-$180K	﹤0.01%	967
2024 Q3	$455K	Buy	24,221 +1,045	+5%	+$20K	﹤0.01%	732
2024 Q2	$438K	Hold	23,176	–	–	﹤0.01%	735
2024 Q1	$376K	Buy	23,176 +1,698	+8%	+$24.9K	﹤0.01%	752
2023 Q4	$272K	Buy	21,478 +295	+1%	+$3.72K	﹤0.01%	799
2023 Q3	$288K	Sell	21,183 -9,460	-31%	-$146K	﹤0.01%	786
2023 Q2	$526K	Sell	30,643 -18,558	-38%	-$288K	﹤0.01%	752
2023 Q1	$685K	Sell	49,201 -1,074	-2%	-$15.8K	﹤0.01%	746
2022 Q4	$673K	Buy	50,275 +417	+0.8%	+$5.39K	﹤0.01%	728
2022 Q3	$594K	Sell	49,858 -1,345	-3%	-$19.1K	﹤0.01%	738
2022 Q2	$652K	Sell	51,203 -31,421	-38%	-$403K	﹤0.01%	719
2022 Q1	$1.07M	Hold	82,624	–	–	﹤0.01%	691
2021 Q4	$1.31M	Sell	82,624 -10,915	-12%	-$186K	﹤0.01%	674
2021 Q3	$1.82M	Sell	93,539 -93,538	-50%	-$1.86M	0.01%	675
2021 Q2	$4.26M	Hold	187,077	–	–	0.01%	655
2021 Q1	$3.44M	Hold	187,077	–	–	0.01%	675
2020 Q4	$15.3M	Sell	187,077 -15,071	-7%	-$197K	0.01%	706
2020 Q3	$2.27M	Sell	202,148 -215,422	-52%	-$2.12M	0.01%	689
2020 Q2	$3.31M	Sell	417,570 -51,586	-11%	-$427K	0.01%	603
2020 Q1	$3.79M	Buy	469,156 +329,466	+236%	+$3.91M	0.03%	418
2019 Q4	$1.76M	Hold	139,690	–	–	0.01%	715
2019 Q3	$1.25M	Buy	139,690 +3,753	+3%	+$32.8K	0.01%	795
2019 Q2	$1.16M	Hold	135,937	–	–	0.01%	791
2019 Q1	$1.03M	Buy	+135,937	New	+$1.09M	0.01%	852
2017 Q4	–	Sell	-1,721	Closed	-$18K	–	1290
2017 Q3	$18K	Hold	1,721	–	–	﹤0.01%	1255
2017 Q2	$14K	Hold	1,721	–	–	﹤0.01%	1266
2017 Q1	$12K	Sell	1,721 -83,887	-98%	-$608K	﹤0.01%	1301
2016 Q4	$611K	Sell	85,608 -60,641	-41%	-$422K	0.01%	989
2016 Q3	$1.06M	Buy	+146,249	New	+$930K	0.01%	743
2015 Q3	–	Sell	-52,306	Closed	-$457K	–	1378
2015 Q2	$457K	Sell	52,306 -15,134	-22%	-$127K	0.01%	923
2015 Q1	$539K	Sell	67,440 -265,519	-80%	-$1.98M	0.01%	882
2014 Q4	$2.58M	Buy	332,959 +254,216	+323%	+$1.85M	0.03%	520
2014 Q3	$510K	Sell	78,743 -27,658	-26%	-$214K	0.02%	745
2014 Q2	$894K	Buy	+106,401	New	+$825K	0.01%	776

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

KBC Group's SEM Position: Q2 2026 in Review

KBC Group reduced its Select Medical (SEM) stake by 42% in Q2 2026, selling an estimated $40.3K and leaving 3,393 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #1673.

KBC Group first reported a position in SEM in Q2 2014 and has held it in 40 quarters since. The position peaked at $15.3M in Q4 2020. 239 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

KBC Group held 3,393 shares of Select Medical worth $56K as of Q2 2026.
KBC Group sold 2,443 Select Medical shares in Q2 2026, an estimated $40.3K.
Select Medical made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1673 holding.
KBC Group first reported a position in Select Medical in Q2 2014 and has held it in 40 quarters since.
KBC Group's Select Medical position peaked at $15.3M in Q4 2020.
239 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.